Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
0.610
-0.005 (-0.78%)
Feb 21, 2025, 4:00 PM EST - Market closed
Generation Bio Co. Employees
Generation Bio Co. had 174 employees as of December 31, 2023. The number of employees increased by 24 or 16.00% compared to the previous year.
Employees
174
Change (1Y)
24
Growth (1Y)
16.00%
Revenue / Employee
$106,793
Profits / Employee
-$836,046
Market Cap
40.76M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 174 | 24 | 16.00% |
| Dec 31, 2022 | 150 | 0 | - |
| Dec 31, 2021 | 150 | 50 | 50.00% |
| Dec 31, 2020 | 100 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
GBIO News
- 16 days ago - Tubulis Strengthens Executive Leadership with Appointment of Matthew Norkunas as Chief Financial Officer and President of Tubulis Inc. - Business Wire
- 6 weeks ago - Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases - GlobeNewsWire
- 4 months ago - Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual Congress - GlobeNewsWire
- 5 months ago - Generation Bio to Present at the 2024 Cantor Global Healthcare Conference - GlobeNewsWire
- 7 months ago - Generation Bio to Present at the Canaccord Genuity 44th Annual Growth Conference - GlobeNewsWire
- 9 months ago - Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit - GlobeNewsWire
- 10 months ago - Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results - GlobeNewsWire
- 10 months ago - Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual Meeting - GlobeNewsWire